Americas in the Spotlight: Roundtable Discussion on the Challenges and Opportunities Related to Pharmaceutical and Biotech Patents

September 29, 2015

Time: Presentation 3:30-5:00 pm; Cocktail reception 5:00-6:30 pm

The Americas contain some of the largest and most rapidly growing economies contributing to the world’s GDP. In this region, the market for pharmaceuticals, biopharmaceuticals and biotechnology products is valued at some of the highest in the world as more governments broaden access to healthcare and life expectancy increases. Given the importance of this market, strong patent protection and enforcement is critical for innovator companies developing new drugs, biopharmaceuticals and treatments for this area. Join the law firm of Michael Best and Friedrich LLP, along with four attorney panelists from Canada, Mexico, Brazil and Columbia for a discussion including informative insight and advice for successfully navigating some of the challenges associated with the intellectual property systems in these countries, and useful strategies for maximizing intellectual property protection.

Discussion Topics Include:

• Patent prosecution in relation to subject matter eligibility, delays and backlogs, unique patentability requirements for pharmaceutical and biotechnology inventions (such as prior approval by ANVISA) and patent reform
• Litigation in terms of patent infringement, patent challenges and miscellaneous topics (such as sham litigation and other regulatory hot topics).